Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

A suppression of differential rotation in Jupiter's deep interior.

Guillot T, Miguel Y, Militzer B, Hubbard WB, Kaspi Y, Galanti E, Cao H, Helled R, Wahl SM, Iess L, Folkner WM, Stevenson DJ, Lunine JI, Reese DR, Biekman A, Parisi M, Durante D, Connerney JEP, Levin SM, Bolton SJ.

Nature. 2018 Mar 7;555(7695):227-230. doi: 10.1038/nature25775.

PMID:
29517000
2.

Jupiter's atmospheric jet streams extend thousands of kilometres deep.

Kaspi Y, Galanti E, Hubbard WB, Stevenson DJ, Bolton SJ, Iess L, Guillot T, Bloxham J, Connerney JEP, Cao H, Durante D, Folkner WM, Helled R, Ingersoll AP, Levin SM, Lunine JI, Miguel Y, Militzer B, Parisi M, Wahl SM.

Nature. 2018 Mar 7;555(7695):223-226. doi: 10.1038/nature25793.

PMID:
29516995
3.

Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis.

Habgood AN, Tatler AL, Porte J, Wahl SM, Laurent GJ, John AE, Johnson SR, Jenkins G.

Lab Invest. 2016 Jun;96(6):623-31. doi: 10.1038/labinvest.2016.40. Epub 2016 Mar 14.

4.

The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.

Zabieglo K, Majewski P, Majchrzak-Gorecka M, Wlodarczyk A, Grygier B, Zegar A, Kapinska-Mrowiecka M, Naskalska A, Pyrc K, Dubin A, Wahl SM, Cichy J.

J Leukoc Biol. 2015 Jul;98(1):99-106. doi: 10.1189/jlb.4AB1114-543R. Epub 2015 Apr 27.

5.

Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome.

Meya DB, Okurut S, Zziwa G, Rolfes MA, Kelsey M, Cose S, Joloba M, Naluyima P, Palmer BE, Kambugu A, Mayanja-Kizza H, Bohjanen PR, Eller MA, Wahl SM, Boulware DR, Manabe YC, Janoff EN.

J Infect Dis. 2015 May 15;211(10):1597-606. doi: 10.1093/infdis/jiu664. Epub 2014 Dec 9.

6.

Memorial: Nancy McCartney-Francis, 1950-2014.

Wahl SM.

J Leukoc Biol. 2014 Nov;96(5):667-8. doi: 10.1189/jlb.4LT0614-301. No abstract available.

7.

Aberrant host defense against Leishmania major in the absence of SLPI.

McCartney-Francis N, Jin W, Belkaid Y, McGrady G, Wahl SM.

J Leukoc Biol. 2014 Nov;96(5):917-29. doi: 10.1189/jlb.4A0612-295RR. Epub 2014 Jul 16.

8.

Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV.

Zhou ZH, Wild T, Xiong Y, Sylvers P, Zhang Y, Zhang L, Wahl L, Wahl SM, Kozlowski S, Notkins AL.

Sci Rep. 2013;3:2271. doi: 10.1038/srep02271.

9.

A link between interferon and augmented plasmin generation in exocrine gland damage in Sjögren's syndrome.

Gliozzi M, Greenwell-Wild T, Jin W, Moutsopoulos NM, Kapsogeorgou E, Moutsopoulos HM, Wahl SM.

J Autoimmun. 2013 Feb;40:122-33. doi: 10.1016/j.jaut.2012.09.003. Epub 2012 Oct 27.

10.

Modulation of innate host factors by Mycobacterium avium complex in human macrophages includes interleukin 17.

Vázquez N, Rekka S, Gliozzi M, Feng CG, Amarnath S, Orenstein JM, Wahl SM.

J Infect Dis. 2012 Oct;206(8):1206-17. Epub 2012 Aug 28.

11.

Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis.

Moutsopoulos NM, Kling HM, Angelov N, Jin W, Palmer RJ, Nares S, Osorio M, Wahl SM.

J Autoimmun. 2012 Dec;39(4):294-303. doi: 10.1016/j.jaut.2012.03.003. Epub 2012 May 3.

12.

Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a.

Hubbard JJ, Greenwell-Wild T, Barrett L, Yang J, Lempicki RA, Wahl SM, Asmuth DM, Murphy RL, Pollard RB, Kottilil S.

J Infect Dis. 2012 May 1;205(9):1443-7. doi: 10.1093/infdis/jis211. Epub 2012 Mar 26.

13.

Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing.

Ashcroft GS, Jeong MJ, Ashworth JJ, Hardman M, Jin W, Moutsopoulos N, Wild T, McCartney-Francis N, Sim D, McGrady G, Song XY, Wahl SM.

Wound Repair Regen. 2012 Jan-Feb;20(1):38-49. doi: 10.1111/j.1524-475X.2011.00748.x. Epub 2011 Dec 8.

14.

Structural variants of IFNα preferentially promote antiviral functions.

Vázquez N, Schmeisser H, Dolan MA, Bekisz J, Zoon KC, Wahl SM.

Blood. 2011 Sep 1;118(9):2567-77. doi: 10.1182/blood-2010-12-325027. Epub 2011 Jul 14.

15.

Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma.

Wen J, Nikitakis NG, Chaisuparat R, Greenwell-Wild T, Gliozzi M, Jin W, Adli A, Moutsopoulos N, Wu T, Warburton G, Wahl SM.

Am J Pathol. 2011 Jun;178(6):2866-78. doi: 10.1016/j.ajpath.2011.02.017.

16.

Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity.

Greenwell-Wild T, Moutsopoulos NM, Gliozzi M, Kapsogeorgou E, Rangel Z, Munson PJ, Moutsopoulos HM, Wahl SM.

Arthritis Rheum. 2011 Oct;63(10):3103-15. doi: 10.1002/art.30465.

17.

HIV infection and specific mucosal immunity: workshop 4B.

Challacombe SJ, Fidel PL Jr, Tugizov S, Tao L, Wahl SM.

Adv Dent Res. 2011 Apr;23(1):142-51. doi: 10.1177/0022034511400222.

PMID:
21441496
18.

Systemic and mucosal differences in HIV burden, immune, and therapeutic responses.

Wahl SM, Redford M, Christensen S, Mack W, Cohn J, Janoff EN, Mestecky J, Jenson HB, Navazesh M, Cohen M, Reichelderfer P, Kovacs A; DATRI 009 Study Group.

J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):401-11. doi: 10.1097/QAI.0b013e31820cdfdb.

19.

Intestinal macrophages and response to microbial encroachment.

Smith PD, Smythies LE, Shen R, Greenwell-Wild T, Gliozzi M, Wahl SM.

Mucosal Immunol. 2011 Jan;4(1):31-42. doi: 10.1038/mi.2010.66. Epub 2010 Oct 20. Review.

20.

Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.

Asmuth DM, Murphy RL, Rosenkranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li XD, Wahl SM, Shore J, Janik J, Lempicki RA, Simpson Y, Pollard RB; AIDS Clinical Trials Group A5192 Team.

J Infect Dis. 2010 Jun 1;201(11):1686-96. doi: 10.1086/652420.

21.

The mouth: a gateway or a trap for HIV?

Malamud D, Wahl SM.

AIDS. 2010 Jan 2;24(1):5-16. doi: 10.1097/QAD.0b013e328333525f. Review. No abstract available.

22.

Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.

Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM.

Am J Pathol. 2009 Sep;175(3):1167-77. doi: 10.2353/ajpath.2009.090319. Epub 2009 Aug 21.

23.

Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon.

Greenwell-Wild T, Vázquez N, Jin W, Rangel Z, Munson PJ, Wahl SM.

Blood. 2009 Aug 27;114(9):1864-74. doi: 10.1182/blood-2009-03-211540. Epub 2009 Jun 25.

24.

TGF-beta can leave you breathless.

Qian BF, Wahl SM.

Curr Opin Pharmacol. 2009 Aug;9(4):454-61. doi: 10.1016/j.coph.2009.04.001. Epub 2009 May 19. Review.

25.

Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic Porphyromonas gingivalis.

Nares S, Moutsopoulos NM, Angelov N, Rangel ZG, Munson PJ, Sinha N, Wahl SM.

Am J Pathol. 2009 Apr;174(4):1400-14. doi: 10.2353/ajpath.2009.080677. Epub 2009 Mar 5.

26.

TGF-beta and tumors--an ill-fated alliance.

Moutsopoulos NM, Wen J, Wahl SM.

Curr Opin Immunol. 2008 Apr;20(2):234-40. doi: 10.1016/j.coi.2008.04.003. Epub 2008 May 15. Review.

27.

Isolation of human monocyte populations.

Wahl LM, Wahl SM, Smythies LE, Smith PD.

Curr Protoc Immunol. 2006 Jan;Chapter 7:Unit 7.6A. doi: 10.1002/0471142735.im0706as70.

PMID:
18432977
28.

Measurement of TGF-beta in biological fluids.

Hale-Donze H, Wahl SM, Jackson RJ, McGhee JR.

Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.11. doi: 10.1002/0471142735.im0611s41.

PMID:
18432803
29.

The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia/reperfusion injury in cardiac transplantation.

Schneeberger S, Hautz T, Wahl SM, Brandacher G, Sucher R, Steinmassl O, Steinmassl P, Wright CD, Obrist P, Werner ER, Mark W, Troppmair J, Margreiter R, Amberger A.

Am J Transplant. 2008 Apr;8(4):773-82. doi: 10.1111/j.1600-6143.2008.02158.x. Epub 2008 Feb 19.

30.

COX inhibitors downregulate PDE4D expression in a clinical model of inflammatory pain.

Wang XM, Hamza M, Gordon SM, Wahl SM, Dionne RA.

Clin Pharmacol Ther. 2008 Jul;84(1):39-42. doi: 10.1038/sj.clpt.6100501. Epub 2008 Feb 20.

PMID:
18288087
31.

Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.

Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM.

Ann Rheum Dis. 2008 Oct;67(10):1437-43. doi: 10.1136/ard.2007.077891. Epub 2008 Jan 15.

PMID:
18198195
32.

Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.

Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK.

Arthritis Rheum. 2007 Dec;56(12):3995-4004.

33.

T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Katsifis GE, Moutsopoulos NM, Wahl SM.

Clin Rev Allergy Immunol. 2007 Jun;32(3):252-64. Review.

PMID:
17992592
34.

Tonsil epithelial factors may influence oropharyngeal human immunodeficiency virus transmission.

Moutsopoulos NM, Nares S, Nikitakis N, Rangel Z, Wen J, Munson P, Sauk J, Wahl SM.

Am J Pathol. 2007 Aug;171(2):571-9. Epub 2007 Jul 9.

35.

Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.

Peng G, Greenwell-Wild T, Nares S, Jin W, Lei KJ, Rangel ZG, Munson PJ, Wahl SM.

Blood. 2007 Jul 1;110(1):393-400. Epub 2007 Mar 19.

36.

Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma.

Warburton G, Nikitakis NG, Roberson P, Marinos NJ, Wu T, Sauk JJ Jr, Ord RA, Wahl SM.

J Oral Maxillofac Surg. 2007 Mar;65(3):475-84.

PMID:
17307596
37.

Transforming growth factor-beta: innately bipolar.

Wahl SM.

Curr Opin Immunol. 2007 Feb;19(1):55-62. Epub 2006 Nov 28. Review.

PMID:
17137775
38.

Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain.

Wang XM, Wu TX, Hamza M, Ramsay ES, Wahl SM, Dionne RA.

Pain. 2007 Mar;128(1-2):136-47. Epub 2006 Oct 27.

39.

Proinflammatory and antimicrobial nitric oxide in gingival fluid of diabetic patients with periodontal disease.

Skaleric U, Gaspirc B, McCartney-Francis N, Masera A, Wahl SM.

Infect Immun. 2006 Dec;74(12):7010-3. Epub 2006 Oct 2.

40.

TGF-beta: a mobile purveyor of immune privilege.

Wahl SM, Wen J, Moutsopoulos N.

Immunol Rev. 2006 Oct;213:213-27. Review.

PMID:
16972906
41.

Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages.

Vázquez N, Greenwell-Wild T, Rekka S, Orenstein JM, Wahl SM.

J Leukoc Biol. 2006 Nov;80(5):1136-44. Epub 2006 Aug 30.

PMID:
16943387
42.

Regulation of the tonsil cytokine milieu favors HIV susceptibility.

Moutsopoulos NM, Vázquez N, Greenwell-Wild T, Ecevit I, Horn J, Orenstein J, Wahl SM.

J Leukoc Biol. 2006 Nov;80(5):1145-55. Epub 2006 Aug 30.

PMID:
16943383
43.

HIV accomplices and adversaries in macrophage infection.

Wahl SM, Greenwell-Wild T, Vázquez N.

J Leukoc Biol. 2006 Nov;80(5):973-83. Epub 2006 Aug 14. Review.

PMID:
16908514
44.

(C3) The oral epithelial cell and first encounters with HIV-1.

Herzberg MC, Weinberg A, Wahl SM.

Adv Dent Res. 2006 Apr 1;19(1):158-66.

PMID:
16672567
45.

Differential mucosal susceptibility in HIV-1 transmission and infection.

Moutsopoulos NM, Greenwell-Wild T, Wahl SM.

Adv Dent Res. 2006 Apr 1;19(1):52-6. Review.

PMID:
16672550
46.

Transforming growth factor-beta induces development of the T(H)17 lineage.

Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT.

Nature. 2006 May 11;441(7090):231-4. Epub 2006 Apr 30.

PMID:
16648837
47.

The kiss of death: interrupted by NK-cell close encounters of another kind.

Wahl SM, Wen J, Moutsopoulos NM.

Trends Immunol. 2006 Apr;27(4):161-4. Epub 2006 Feb 28. Review.

PMID:
16504582
48.

Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.

Peng G, Lei KJ, Jin W, Greenwell-Wild T, Wahl SM.

J Exp Med. 2006 Jan 23;203(1):41-6. Epub 2006 Jan 17. Erratum in: J Exp Med. 2006 Dec 25;203(13):2963.

49.

Immunological consequences of thalidomide treatment in Sjögren's syndrome.

Moutsopoulos NM, Angelov N, Sankar V, Leakan RA, Pillemer S, Wahl SM.

Ann Rheum Dis. 2006 Jan;65(1):112-4.

50.

Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation.

Vázquez N, Greenwell-Wild T, Marinos NJ, Swaim WD, Nares S, Ott DE, Schubert U, Henklein P, Orenstein JM, Sporn MB, Wahl SM.

J Virol. 2005 Apr;79(7):4479-91.

Supplemental Content

Support Center